 At Visit 3 12-18 weeks patients with LDL 2.5 mmolL will be treated with combination of statin and ezetimibe 10 mg addedstarted as per Study Schematic Table 1 in order to achieve the recommended target of LDL2.5 mmolL and providing that this treatment is in the best interest of the patient. 